To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

Clinical trial NCT06488911 · TERMINATED

Trial details

NCT number: NCT06488911
Sponsor: Intercept Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2024-07-01
Primary completion: 2025-10-21
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.